Jacques Sayegh, CFA, MBA, BSc

CEO and Managing Partner, Samuel Capital Partners

Jacques Sayegh, CIMTEC board member

Mr. Jacques Sayegh is the CEO and Managing Partner of Samuel Capital Partners, a private equity group focused on emerging medical technology companies in Canada and Israel. Mr. Sayegh has over 30 years of experience in the development and financing of growth companies as an executive, angel, mentor, and venture capitalist.

Prior to his role at Samuel, from 1990 to 1999 he served as President and Chief Executive Officer of Royal Bank Capital Corporation, and subsequently founded several successful medtech ventures including VisualSonics, an imaging company spun-off from Sunnybrook Health Sciences Centre.

Mr. Sayegh has served on the Investment Advisory Boards of MDS Life Sciences Fund, Genechem Technologies Fund, BC Life Sciences Fund, Burrill Agri Sciences Fund, Ontario Rehabilitation Technologies Consortium, and the NeuroSciences Partners Fund. For eight year, he also served as a Director of the Canadian Venture Capital Association.


CEO and Managing Partner, Samuel Capital Partners